Clinical Proteomics, 2015 A novel multiplexed immunoassay identifies CEA, IL-8 and prolactin as prospective markers for Dukes’ stages A-D colorectal cancers Mahboob S., Ahn S., Cheruku H. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
PLOS ONE, 2015 Low Elastin Content of Carotid Plaques Is Associated with Increased Risk of Ipsilateral Stroke Asciutto G., Dias N., Edsfeldt A. et al. Olink Target 96CVDNeurologyPatient StratificationBlood | | | | |
Frontiers in Neurology, 2014 Cerebral Microdialysis for Protein Biomarker Monitoring in the Neurointensive Care Setting – A Technical Approach Hillered L., Dahlin A., Clausen F. et al. NeurologyTechnology Evaluation | | | | |
PLoS ONE, 2014 Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability Assarsson E., Lundberg M., Holmquist G. et al. | | | | |
PROTEOMICS, 2014 Antibody‐based proteomics and biomarker research—Current status and limitations Solier C., Langen H. Technical StudiesTechnology Evaluation | | | | |
Archives of Microbiology & Immunology, 2022 Circulating Cell-Free DNA and Systemic Inflammatory Response after Self-Expandable Metal Stent for Malignant Bowel Obstruction Broholm M, Bojesen R, Gögenur M et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Diagnostics, 2022 Proteomic Analysis of Pleural Effusions from COVID-19 Deceased Patients: Enhanced Inflammatory Markers Razaghi A., Szakos A., Alouda M. et al. Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPleural Effusion Fluid | | | | |
European Heart Journal Open, 2022 NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients Rossignol P., Duarte K., Bresso E. et al. Olink Target 96CVDNephrologyPathophysiologyPatient StratificationPlasma | | | | |
Obesity, 2022 The inflammatory proteome, obesity, and medical weight loss and regain in humans Perry A., Tanriverdi K., Risitano A. et al. Olink Target 96Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma | | | | |
Clinical and Translational Science, 2022 ST2 and CSF‐1 as potential druggable targets of inflammatory bowel diseases: Results from two‐sample Mendelian randomization study Mi J., Wu X., Bai X. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Journal of Clinical Immunology, 2022 Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients Ebihara T., Matsubara T., Togami Y. et al. Olink Explore 3072/384Infectious DiseasesPathophysiologyPlasma | | | | |
Obesity, 2022 Proteomics, dietary intake, and changes in cardiometabolic health within a behavioral weight‐loss intervention: A pilot study Hill E., Siebert J., Yazza D. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Cell Systems, 2022 Pre-infection antiviral innate immunity contributes to sex differences in SARS-CoV-2 infection Sauerwald N., Zhang Z., Ramos I. et al. Olink Target 96Infectious DiseasesPathophysiologySerum | | | | |
Journal for ImmunoTherapy of Cancer, 2022 First-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors Davis E., Martin-Liberal J., Kristeleit R. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |
Allergy, 2022 Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation: A 24‐year follow‐up Tedner S., Klevebro S., Bergström A. et al. Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Journal of Proteome Research, 2022 Plasma Olink Proteomics Identifies CCL20 as a Novel Predictive and Diagnostic Inflammatory Marker for Preeclampsia Wang X., Yip K., He A. et al. Olink Target 96ObstetricsPatient StratificationPlasma | | | | |
Immunity, Inflammation and Disease, 2022 Exploratory analysis of interleukin‐38 in hospitalized COVID‐19 patients de Graaf D., Teufel L., de Nooijer A. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Nature Genetics, 2022 Multiomics study of nonalcoholic fatty liver disease Sveinbjornsson G., Ulfarsson M., Thorolfsdottir R. et al. Olink Explore 3072/384HepatologyPathophysiologyPatient StratificationPlasma | | | | |
Movement Disorders, 2022 Blood Markers of Inflammation, Neurodegeneration, and Cardiovascular Risk in Early Parkinson's Disease Bartl M., Dakna M., Schade S. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationPlasma | | | | |
Nature Communications, 2022 Reprogramming of myeloid cells and their progenitors in patients with non-medullary thyroid carcinoma Rabold K., Zoodsma M., Grondman I. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |